Goldline Pharmac

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1CLW01015
  • NSEID:
  • BSEID: 544759
INR
46.14
2.19 (4.98%)
BSENSE

May 27

BSE+NSE Vol: 363000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Goldline Pharmaceutical Ltd stock-summary
stock-summary
Goldline Pharmaceutical Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of `Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to `Goldline Pharmaceutical Limited' w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 15 FIIs (5.16%)

Promoter with highest holding

Amol Laxmikant Mujumdar (28.65%)

Highest Public shareholder

Sumit Bilgaiyan (7.03%)

Individual Investors Holdings

25.14%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 40 Cr (Micro Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.73

stock-summary
Return on Equity

27.33%

stock-summary
Price to Book

4.08